Another disease associated with Asn bioavailability is asparagine synthetase deficiency (ASNSD), which was first described in 2013 as an inborn error of metabolism caused by deleterious biallelic mutations in the ASNS gene [17]. The gene discussed is ASNS; the disease is congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome.